Form 4 filings across 6 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$14.3M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 17 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 48 most recent Form 4 transactions.
| Aug 4 | GH | Guardant Health, Inc. | SSELL | 5,092 | $158.80 | $808.6K | -63.1% | Open the original filing on SEC.gov |
| Aug 4 | GH | Guardant Health, Inc. | SSELL | 9,088 | $158.98 | $1.4M | -53.0% | Open the original filing on SEC.gov |
| Aug 4 | GH | Guardant Health, Inc. | MEXER | 6,833 | $50.57 | $345.5K | +66.2% | Open the original filing on SEC.gov |
| Aug 4 | GH | Guardant Health, Inc. | MEXER | 2,255 | $91.11 | $205.5K | +28.0% | Open the original filing on SEC.gov |
| Jun 18 | OLMA | Olema Pharmaceuticals,… | AGRANT◆ | 29,500 | — | — | — | Open the original filing on SEC.gov |
| Jun 17 | GH | Guardant Health, Inc. | AGRANT◆ | 2,711 | — | — | — | Open the original filing on SEC.gov |
| Jun 17 | GH | Guardant Health, Inc. | MEXER◆ | 5,092 | — | — | — | Open the original filing on SEC.gov |
| Jun 17 | GH | Guardant Health, Inc. | MEXER | 5,092 | — | — | +171.2% | Open the original filing on SEC.gov |
| Jun 11 | CRVS | Corvus Pharmaceuticals,… | AGRANT◆ | 15,000 | — | — | — | Open the original filing on SEC.gov |
| Jun 2 | BMRN | Biomarin Pharmaceutical… | AGRANT | 7,490 | — | — | +107.0% | Open the original filing on SEC.gov |
| May 27 | KYTX | Kyverna Therapeutics, Inc. | AGRANT◆ | 20,582 | — | — | — | Open the original filing on SEC.gov |
| May 27 | KYTX | Kyverna Therapeutics, Inc. | AGRANT | 5,093 | — | — | +30.6% | Open the original filing on SEC.gov |
| May 20 | GH | Guardant Health, Inc. | SSELL | 6,876 | $106.90 | $735K | -69.8% | Open the original filing on SEC.gov |
| Dec 19, 2025 | OLMA | Olema Pharmaceuticals,… | MEXER◆ | 12,070 | — | — | — | Open the original filing on SEC.gov |
| Dec 19, 2025 | OLMA | Olema Pharmaceuticals,… | MEXER◆ | 21,520 | — | — | — | Open the original filing on SEC.gov |
| Dec 19, 2025 | OLMA | Olema Pharmaceuticals,… | MEXER◆ | 21,520 | — | — | — | Open the original filing on SEC.gov |
| Dec 19, 2025 | OLMA | Olema Pharmaceuticals,… | MEXER◆ | 209,690 | — | — | — | Open the original filing on SEC.gov |
| Dec 19, 2025 | OLMA | Olema Pharmaceuticals,… | SSELL | 41,840 | $30.48 | $1.3M | -100.0% | Open the original filing on SEC.gov |
| Dec 19, 2025 | OLMA | Olema Pharmaceuticals,… | SSELL | 193,056 | $29.71 | $5.7M | -82.2% | Open the original filing on SEC.gov |
| Dec 19, 2025 | OLMA | Olema Pharmaceuticals,… | SSELL | 29,904 | $28.83 | $862.1K | -11.3% | Open the original filing on SEC.gov |
| Dec 19, 2025 | OLMA | Olema Pharmaceuticals,… | MEXER | 12,070 | $4.08 | $49.2K | +4.8% | Open the original filing on SEC.gov |
| Dec 19, 2025 | OLMA | Olema Pharmaceuticals,… | MEXER | 21,520 | $7.84 | $168.7K | +9.3% | Open the original filing on SEC.gov |
| Dec 19, 2025 | OLMA | Olema Pharmaceuticals,… | MEXER | 21,520 | $3.61 | $77.7K | +10.3% | Open the original filing on SEC.gov |
| Dec 19, 2025 | OLMA | Olema Pharmaceuticals,… | MEXER | 209,690 | $4.41 | $923.9K | — | Open the original filing on SEC.gov |
| Dec 5, 2025 | GH | Guardant Health, Inc. | MEXER◆ | 10,703 | — | — | — | Open the original filing on SEC.gov |
| Dec 5, 2025 | GH | Guardant Health, Inc. | MEXER◆ | 8,803 | — | — | — | Open the original filing on SEC.gov |
| Dec 5, 2025 | GH | Guardant Health, Inc. | MEXER◆ | 9,105 | — | — | — | Open the original filing on SEC.gov |
| Dec 5, 2025 | GH | Guardant Health, Inc. | SSELL | 3,400 | $108.05 | $367.4K | -25.7% | Open the original filing on SEC.gov |
| Dec 5, 2025 | GH | Guardant Health, Inc. | SSELL | 17,055 | $107.27 | $1.8M | -56.3% | Open the original filing on SEC.gov |
| Dec 5, 2025 | GH | Guardant Health, Inc. | SSELL | 8,156 | $106.67 | $870K | -21.2% | Open the original filing on SEC.gov |
| Dec 5, 2025 | GH | Guardant Health, Inc. | MEXER | 10,703 | $31.84 | $340.8K | +38.6% | Open the original filing on SEC.gov |
| Dec 5, 2025 | GH | Guardant Health, Inc. | MEXER | 8,803 | $38.01 | $334.6K | +46.4% | Open the original filing on SEC.gov |
| Dec 5, 2025 | GH | Guardant Health, Inc. | MEXER | 9,105 | $38.42 | $349.8K | +92.4% | Open the original filing on SEC.gov |
| Aug 1, 2025 | BMRN | Biomarin Pharmaceutical… | AGRANT | 7,000 | — | — | — | Open the original filing on SEC.gov |
| Jul 8, 2025 | GDRX | GoodRx Holdings, Inc. | MEXER◆ | 17,248 | — | — | — | Open the original filing on SEC.gov |
| Jul 8, 2025 | GDRX | GoodRx Holdings, Inc. | MEXER | 17,248 | $4.74 | $81.8K | +20.8% | Open the original filing on SEC.gov |
| Jun 18, 2025 | GH | Guardant Health, Inc. | AGRANT◷◆ | 5,092 | — | — | — | Open the original filing on SEC.gov |
| Jun 18, 2025 | GH | Guardant Health, Inc. | AGRANT◷◆ | 6,833 | — | — | — | Open the original filing on SEC.gov |
| Jun 17, 2025 | GH | Guardant Health, Inc. | SSELL◷ | 6,672 | $48.38 | $322.8K | -40.4% | Open the original filing on SEC.gov |
| Jun 12, 2025 | CRVS | Corvus Pharmaceuticals,… | AGRANT◆ | 15,000 | — | — | — | Open the original filing on SEC.gov |
| Jun 12, 2025 | GH | Guardant Health, Inc. | MEXER◆ | 8,088 | — | — | — | Open the original filing on SEC.gov |
| Jun 12, 2025 | GH | Guardant Health, Inc. | MEXER | 8,088 | — | — | +95.9% | Open the original filing on SEC.gov |
| Jun 11, 2025 | OLMA | Olema Pharmaceuticals,… | AGRANT◆ | 24,150 | — | — | — | Open the original filing on SEC.gov |
| Jun 3, 2025 | GDRX | GoodRx Holdings, Inc. | AGRANT | 57,050 | — | — | +220.7% | Open the original filing on SEC.gov |
| May 29, 2025 | KYTX | Kyverna Therapeutics, Inc. | AGRANT◆ | 65,351 | — | — | — | Open the original filing on SEC.gov |
| May 29, 2025 | KYTX | Kyverna Therapeutics, Inc. | AGRANT | 16,634 | — | — | — | Open the original filing on SEC.gov |